CCIA
Campbell & Co Investment Adviser’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-904
| Closed | -$271K | – | 1414 |
|
|
2024
Q3 | $271K | Buy |
+904
| New | +$271K | 0.02% | 935 |
|
|
2024
Q2 | – | Sell |
-1,785
| Closed | -$706K | – | 1386 |
|
|
2024
Q1 | $706K | Sell |
1,785
-1,511
| -46% | -$598K | 0.06% | 547 |
|
|
2023
Q4 | $1.16M | Sell |
3,296
-450
| -12% | -$158K | 0.1% | 323 |
|
|
2023
Q3 | $1.41M | Buy |
3,746
+1,452
| +63% | +$545K | 0.17% | 168 |
|
|
2023
Q2 | $877K | Buy |
+2,294
| New | +$877K | 0.16% | 200 |
|
|
2023
Q1 | – | Sell |
-951
| Closed | -$224K | – | 1059 |
|
|
2022
Q4 | $224K | Sell |
951
-2,407
| -72% | -$566K | 0.05% | 657 |
|
|
2022
Q3 | $826K | Sell |
3,358
-659
| -16% | -$162K | 0.19% | 172 |
|
|
2022
Q2 | $1.22M | Buy |
4,017
+3,490
| +662% | +$1.06M | 0.33% | 48 |
|
|
2022
Q1 | $216K | Sell |
527
-79
| -13% | -$32.4K | 0.06% | 598 |
|
|
2021
Q4 | $284K | Sell |
606
-500
| -45% | -$234K | 0.1% | 386 |
|
|
2021
Q3 | $470K | Buy |
1,106
+450
| +69% | +$191K | 0.15% | 234 |
|
|
2021
Q2 | $236K | Buy |
+656
| New | +$236K | 0.1% | 399 |
|
|
2019
Q4 | – | Sell |
-1,565
| Closed | -$222K | – | 873 |
|
|
2019
Q3 | $222K | Buy |
+1,565
| New | +$222K | 0.08% | 509 |
|
|
2017
Q4 | – | Sell |
-3,001
| Closed | -$289K | – | 526 |
|
|
2017
Q3 | $289K | Buy |
+3,001
| New | +$289K | 0.23% | 170 |
|
|
2017
Q2 | – | Sell |
-4,143
| Closed | -$338K | – | 379 |
|
|
2017
Q1 | $338K | Buy |
+4,143
| New | +$338K | 0.87% | 39 |
|
|
2016
Q4 | – | Sell |
-5,358
| Closed | -$399K | – | 205 |
|
|
2016
Q3 | $399K | Buy |
+5,358
| New | +$399K | 1.07% | 21 |
|
|
2015
Q1 | – | Sell |
-29,652
| Closed | -$1.58M | – | 292 |
|
|
2014
Q4 | $1.58M | Buy |
+29,652
| New | +$1.58M | 0.97% | 25 |
|
|
2014
Q2 | – | Sell |
-46,124
| Closed | -$2.03M | – | 253 |
|
|
2014
Q1 | $2.03M | Buy |
+46,124
| New | +$2.03M | 0.82% | 43 |
|